Smith & Nephew plc Logo

Smith & Nephew plc

SNNUF

(1.8)
Stock Price

12,18 USD

5.56% ROA

6.76% ROE

32.26x PER

Market Cap.

11.335.662.000,00 USD

67.68% DER

2.89% Yield

4.96% NPM

Smith & Nephew plc Stock Analysis

Smith & Nephew plc Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Smith & Nephew plc Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

2 Dividend

The company's consistent dividend distribution over the past five years reflects its dedication to providing shareholders with steady returns, making it an appealing choice for investors seeking income stability.

3 ROE

The stock's ROE falls within an average range (4.12%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (3.91%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 DER

The stock has a reasonable amount of debt compared to its ownership (55%), suggesting a balanced financial position and a moderate level of risk.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Smith & Nephew plc Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Smith & Nephew plc Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Smith & Nephew plc Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Smith & Nephew plc Revenue
Year Revenue Growth
1985 609.395.934
1986 709.766.121 14.14%
1987 1.023.738.594 30.67%
1988 1.077.374.945 4.98%
1989 1.139.441.591 5.45%
1990 1.407.546.005 19.05%
1991 1.481.419.108 4.99%
1992 1.300.866.030 -13.88%
1993 1.403.319.330 7.3%
1994 1.508.059.346 6.95%
1995 1.585.852.030 4.91%
1996 1.831.010.035 13.39%
1997 1.732.625.801 -5.68%
1998 1.748.526.848 0.91%
1999 1.811.666.882 3.49%
2000 1.694.796.271 -6.9%
2001 1.575.172.000 -7.59%
2002 1.787.710.397 11.89%
2003 2.105.178.571 15.08%
2004 2.394.698.480 12.09%
2005 2.552.000.000 6.16%
2006 2.779.000.000 8.17%
2007 3.369.000.000 17.51%
2008 3.801.000.000 11.37%
2009 3.772.000.000 -0.77%
2010 3.962.000.000 4.8%
2011 4.270.000.000 7.21%
2012 4.137.000.000 -3.21%
2013 4.351.000.000 4.92%
2014 4.617.000.000 5.76%
2015 4.634.000.000 0.37%
2016 4.669.000.000 0.75%
2017 4.765.000.000 2.01%
2018 4.904.000.000 2.83%
2019 5.138.000.000 4.55%
2020 4.560.000.000 -12.68%
2021 5.212.000.000 12.51%
2022 5.215.000.000 0.06%
2023 5.682.688.976 8.23%
2024 5.654.000.000 -0.51%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Smith & Nephew plc Research and Development Expenses
Year Research and Development Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 23.785.498 100%
1989 22.785.622 -4.39%
1990 32.791.944 30.51%
1991 37.797.986 13.24%
1992 36.855.595 -2.56%
1993 43.044.790 14.38%
1994 45.338.711 5.06%
1995 45.429.260 0.2%
1996 70.726.444 35.77%
1997 69.265.357 -2.11%
1998 71.541.206 3.18%
1999 73.120.227 2.16%
2000 69.303.381 -5.51%
2001 74.121.000 6.5%
2002 98.785.000 24.97%
2003 119.285.714 17.19%
2004 127.359.214 6.34%
2005 122.000.000 -4.39%
2006 120.000.000 -1.67%
2007 142.000.000 15.49%
2008 152.000.000 6.58%
2009 155.000.000 1.94%
2010 151.000.000 -2.65%
2011 167.000.000 9.58%
2012 171.000.000 2.34%
2013 231.000.000 25.97%
2014 235.000.000 1.7%
2015 222.000.000 -5.86%
2016 230.000.000 3.48%
2017 223.000.000 -3.14%
2018 246.000.000 9.35%
2019 292.000.000 15.75%
2020 307.000.000 4.89%
2021 356.000.000 13.76%
2022 345.000.000 -3.19%
2023 347.167.338 0.62%
2024 274.000.000 -26.7%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Smith & Nephew plc General and Administrative Expenses
Year General and Administrative Expenses Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 750.089.000 100%
2002 872.144.000 13.99%
2003 975.535.714 10.6%
2004 1.146.232.929 14.89%
2005 689.000.000 -66.36%
2006 1.319.000.000 47.76%
2007 1.740.000.000 24.2%
2008 1.942.000.000 10.4%
2009 1.864.000.000 -4.18%
2010 1.860.000.000 -0.22%
2011 2.101.000.000 11.47%
2012 2.050.000.000 -2.49%
2013 2.210.000.000 7.24%
2014 2.471.000.000 10.56%
2015 2.641.000.000 6.44%
2016 2.366.000.000 -11.62%
2017 2.360.000.000 -0.25%
2018 2.497.000.000 5.49%
2019 2.693.000.000 7.28%
2020 2.562.000.000 -5.11%
2021 2.720.000.000 5.81%
2022 2.880.000.000 5.56%
2023 384.000.000 -650%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Smith & Nephew plc EBITDA
Year EBITDA Growth
1985 148.099.059
1986 179.178.616 17.35%
1987 279.729.451 35.95%
1988 295.156.407 5.23%
1989 314.826.700 6.25%
1990 390.417.036 19.36%
1991 362.636.128 -7.66%
1992 305.764.943 -18.6%
1993 317.140.997 3.59%
1994 342.698.122 7.46%
1995 353.544.718 3.07%
1996 396.958.591 10.94%
1997 353.600.476 -12.26%
1998 349.074.612 -1.3%
1999 381.454.639 8.49%
2000 372.655.036 -2.36%
2001 315.268.000 -18.2%
2002 438.431.183 28.09%
2003 553.392.857 20.77%
2004 636.604.265 13.07%
2005 710.000.000 10.34%
2006 748.000.000 5.08%
2007 862.000.000 13.23%
2008 936.000.000 7.91%
2009 1.039.000.000 9.91%
2010 1.211.000.000 14.2%
2011 1.166.000.000 -3.86%
2012 1.182.000.000 1.35%
2013 1.196.000.000 1.17%
2014 1.188.000.000 -0.67%
2015 1.119.000.000 -6.17%
2016 1.266.000.000 11.61%
2017 1.396.000.000 9.31%
2018 1.294.000.000 -7.88%
2019 1.326.000.000 2.41%
2020 904.000.000 -46.68%
2021 1.172.000.000 22.87%
2022 943.000.000 -24.28%
2023 1.153.128.095 18.22%
2024 1.040.000.000 -10.88%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Smith & Nephew plc Gross Profit
Year Gross Profit Growth
1985 609.395.934
1986 709.766.121 14.14%
1987 1.023.738.594 30.67%
1988 1.077.374.945 4.98%
1989 1.139.441.591 5.45%
1990 1.407.546.005 19.05%
1991 1.481.419.108 4.99%
1992 1.300.866.030 -13.88%
1993 1.403.319.330 7.3%
1994 1.508.059.346 6.95%
1995 1.585.852.030 4.91%
1996 1.831.010.035 13.39%
1997 1.732.625.801 -5.68%
1998 1.748.526.848 0.91%
1999 1.811.666.882 3.49%
2000 1.694.796.271 -6.9%
2001 1.065.211.000 -59.1%
2002 1.256.076.397 15.2%
2003 1.488.928.571 15.64%
2004 1.752.531.839 15.04%
2005 1.851.000.000 5.32%
2006 2.010.000.000 7.91%
2007 2.375.000.000 15.37%
2008 2.724.000.000 12.81%
2009 2.742.000.000 0.66%
2010 2.931.000.000 6.45%
2011 3.130.000.000 6.36%
2012 3.067.000.000 -2.05%
2013 3.251.000.000 5.66%
2014 3.455.000.000 5.9%
2015 3.491.000.000 1.03%
2016 3.397.000.000 -2.77%
2017 3.517.000.000 3.41%
2018 3.606.000.000 2.47%
2019 3.800.000.000 5.11%
2020 3.164.000.000 -20.1%
2021 3.669.000.000 13.76%
2022 3.675.000.000 0.16%
2023 3.911.009.047 6.03%
2024 3.948.000.000 0.94%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Smith & Nephew plc Net Profit
Year Net Profit Growth
1985 68.430.985
1986 89.293.634 23.36%
1987 140.520.487 36.46%
1988 145.235.692 3.25%
1989 147.625.160 1.62%
1990 143.127.194 -3.14%
1991 74.660.379 -91.7%
1992 155.915.853 52.11%
1993 160.789.302 3.03%
1994 -84.267.467 290.81%
1995 174.300.018 148.35%
1996 206.699.318 15.67%
1997 187.958.738 -9.97%
1998 155.531.579 -20.85%
1999 169.535.395 8.26%
2000 309.923.527 45.3%
2001 188.724.000 -64.22%
2002 184.746.718 -2.15%
2003 264.464.285 30.14%
2004 290.010.741 8.81%
2005 333.000.000 12.91%
2006 745.000.000 55.3%
2007 316.000.000 -135.76%
2008 377.000.000 16.18%
2009 472.000.000 20.13%
2010 615.000.000 23.25%
2011 582.000.000 -5.67%
2012 729.000.000 20.16%
2013 556.000.000 -31.12%
2014 501.000.000 -10.98%
2015 410.000.000 -22.2%
2016 784.000.000 47.7%
2017 767.000.000 -2.22%
2018 663.000.000 -15.69%
2019 600.000.000 -10.5%
2020 448.000.000 -33.93%
2021 524.000.000 14.5%
2022 223.000.000 -134.98%
2023 263.000.000 15.21%
2024 428.000.000 38.55%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Smith & Nephew plc Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1985 0
1986 0 0%
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 1 0%
2007 0 0%
2008 0 0%
2009 1 0%
2010 1 0%
2011 1 0%
2012 1 0%
2013 1 0%
2014 1 0%
2015 0 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%
2020 1 0%
2021 1 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Smith & Nephew plc Free Cashflow
Year Free Cashflow Growth
1991 23.764.080
1992 6.521.771 -264.38%
1993 -54.434.650 111.98%
1994 17.353.781 413.68%
1995 -35.694.419 148.62%
1996 17.638.797 302.36%
1997 -5.785.889 404.86%
1998 2.157.855 368.13%
1999 6.470.816 66.65%
2000 -581.461.345 101.11%
2001 35.677.000 1729.79%
2002 105.553.000 66.2%
2003 146.428.571 27.92%
2004 167.726.650 12.7%
2005 60.000.000 -179.54%
2006 130.000.000 53.85%
2007 230.000.000 43.48%
2008 277.000.000 16.97%
2009 401.000.000 30.92%
2010 544.000.000 26.29%
2011 521.000.000 -4.41%
2012 637.000.000 18.21%
2013 527.000.000 -20.87%
2014 308.000.000 -71.1%
2015 672.000.000 54.17%
2016 457.000.000 -47.05%
2017 714.000.000 35.99%
2018 584.000.000 -22.26%
2019 760.000.000 23.16%
2020 492.000.000 -54.47%
2021 469.000.000 -4.9%
2022 110.000.000 -326.36%
2023 185.360.733 40.66%
2024 33.000.000 -461.7%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Smith & Nephew plc Operating Cashflow
Year Operating Cashflow Growth
1991 106.470.566
1992 76.137.897 -39.84%
1993 43.340.630 -75.67%
1994 117.098.947 62.99%
1995 72.470.486 -61.58%
1996 142.137.890 49.01%
1997 113.568.736 -25.16%
1998 117.188.148 3.09%
1999 115.018.765 -1.89%
2000 -486.019.835 123.67%
2001 144.455.000 436.45%
2002 242.853.000 40.52%
2003 276.785.714 12.26%
2004 363.280.650 23.81%
2005 260.000.000 -39.72%
2006 352.000.000 26.14%
2007 424.000.000 16.98%
2008 566.000.000 25.09%
2009 719.000.000 21.28%
2010 859.000.000 16.3%
2011 842.000.000 -2.02%
2012 902.000.000 6.65%
2013 867.000.000 -4.04%
2014 683.000.000 -26.94%
2015 1.030.000.000 33.69%
2016 849.000.000 -21.32%
2017 1.090.000.000 22.11%
2018 931.000.000 -17.08%
2019 1.168.000.000 20.29%
2020 935.000.000 -24.92%
2021 877.000.000 -6.61%
2022 468.000.000 -87.39%
2023 622.648.206 24.84%
2024 119.000.000 -423.23%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Smith & Nephew plc Capital Expenditure
Year Capital Expenditure Growth
1991 82.706.486
1992 69.616.125 -18.8%
1993 97.775.280 28.8%
1994 99.745.165 1.97%
1995 108.164.905 7.78%
1996 124.499.092 13.12%
1997 119.354.625 -4.31%
1998 115.030.293 -3.76%
1999 108.547.949 -5.97%
2000 95.441.510 -13.73%
2001 108.778.000 12.26%
2002 137.300.000 20.77%
2003 130.357.143 -5.33%
2004 195.554.000 33.34%
2005 200.000.000 2.22%
2006 222.000.000 9.91%
2007 194.000.000 -14.43%
2008 289.000.000 32.87%
2009 318.000.000 9.12%
2010 315.000.000 -0.95%
2011 321.000.000 1.87%
2012 265.000.000 -21.13%
2013 340.000.000 22.06%
2014 375.000.000 9.33%
2015 358.000.000 -4.75%
2016 392.000.000 8.67%
2017 376.000.000 -4.26%
2018 347.000.000 -8.36%
2019 408.000.000 14.95%
2020 443.000.000 7.9%
2021 408.000.000 -8.58%
2022 358.000.000 -13.97%
2023 437.287.473 18.13%
2024 86.000.000 -408.47%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Smith & Nephew plc Equity
Year Equity Growth
1985 273.147.681
1986 310.901.510 12.14%
1987 445.730.987 30.25%
1988 433.184.373 -2.9%
1989 401.315.788 -7.94%
1990 520.427.452 22.89%
1991 538.153.511 3.29%
1992 548.890.539 1.96%
1993 513.726.998 -6.84%
1994 696.652.752 26.26%
1995 624.884.109 -11.49%
1996 745.110.799 16.14%
1997 762.084.242 2.23%
1998 805.378.039 5.38%
1999 892.002.070 9.71%
2000 399.838.690 -123.09%
2001 589.179.000 32.14%
2002 833.212.531 29.29%
2003 1.144.285.714 27.18%
2004 1.346.478.441 15.02%
2005 1.435.000.000 6.17%
2006 2.174.000.000 33.99%
2007 1.816.000.000 -19.71%
2008 1.699.000.000 -6.89%
2009 2.179.000.000 22.03%
2010 2.773.000.000 21.42%
2011 3.187.000.000 12.99%
2012 3.884.000.000 17.95%
2013 4.047.000.000 4.03%
2014 4.040.000.000 -0.17%
2015 3.966.000.000 -1.87%
2016 3.958.000.000 -0.2%
2017 4.644.000.000 14.77%
2018 4.874.000.000 4.72%
2019 5.141.000.000 5.19%
2020 5.279.000.000 2.61%
2021 5.568.000.000 5.19%
2022 5.259.000.000 -5.88%
2023 5.209.633.668 -0.95%
2024 5.205.823.510 -0.07%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Smith & Nephew plc Assets
Year Assets Growth
1985 643.395.329
1986 888.501.227 27.59%
1987 1.227.399.621 27.61%
1988 1.273.064.725 3.59%
1989 1.353.016.688 5.91%
1990 1.533.698.545 11.78%
1991 1.582.650.349 3.09%
1992 1.344.546.736 -17.71%
1993 1.306.875.332 -2.88%
1994 1.321.857.949 1.13%
1995 1.272.482.848 -3.88%
1996 1.441.586.464 11.73%
1997 1.427.130.860 -1.01%
1998 1.502.697.319 5.03%
1999 1.585.835.382 5.24%
2000 1.437.447.723 -10.32%
2001 1.598.762.000 10.09%
2002 1.993.074.011 19.78%
2003 2.222.678.571 10.33%
2004 2.919.479.822 23.87%
2005 2.976.000.000 1.9%
2006 3.231.000.000 7.89%
2007 4.461.000.000 27.57%
2008 4.508.000.000 1.04%
2009 4.565.000.000 1.25%
2010 4.733.000.000 3.55%
2011 4.747.000.000 0.29%
2012 5.642.000.000 15.86%
2013 5.819.000.000 3.04%
2014 7.306.000.000 20.35%
2015 7.167.000.000 -1.94%
2016 7.344.000.000 2.41%
2017 7.866.000.000 6.64%
2018 8.059.000.000 2.39%
2019 9.299.000.000 13.33%
2020 11.012.000.000 15.56%
2021 10.920.000.000 -0.84%
2022 9.966.000.000 -9.57%
2023 9.972.898.493 0.07%
2024 10.543.667.906 5.41%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Smith & Nephew plc Liabilities
Year Liabilities Growth
1985 369.815.452
1986 577.156.204 35.92%
1987 781.106.552 26.11%
1988 839.339.772 6.94%
1989 951.219.512 11.76%
1990 1.012.692.411 6.07%
1991 1.043.935.481 2.99%
1992 795.201.189 -31.28%
1993 792.704.573 -0.31%
1994 624.736.175 -26.89%
1995 647.135.175 3.46%
1996 695.961.913 7.02%
1997 664.550.684 -4.73%
1998 696.821.312 4.63%
1999 693.348.000 -0.5%
2000 1.037.609.033 33.18%
2001 1.009.583.000 -2.78%
2002 1.159.861.480 12.96%
2003 1.078.392.857 -7.55%
2004 1.573.001.381 31.44%
2005 1.541.000.000 -2.08%
2006 1.057.000.000 -45.79%
2007 2.645.000.000 60.04%
2008 2.809.000.000 5.84%
2009 2.386.000.000 -17.73%
2010 1.960.000.000 -21.73%
2011 1.560.000.000 -25.64%
2012 1.758.000.000 11.26%
2013 1.772.000.000 0.79%
2014 3.266.000.000 45.74%
2015 3.201.000.000 -2.03%
2016 3.386.000.000 5.46%
2017 3.222.000.000 -5.09%
2018 3.185.000.000 -1.16%
2019 4.158.000.000 23.4%
2020 5.733.000.000 27.47%
2021 5.352.000.000 -7.12%
2022 4.707.000.000 -13.7%
2023 4.763.264.825 1.18%
2024 5.337.844.395 10.76%

Smith & Nephew plc Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
8.12
Net Income per Share
0.4
Price to Earning Ratio
32.26x
Price To Sales Ratio
1.6x
POCF Ratio
11.51
PFCF Ratio
26.79
Price to Book Ratio
2.18
EV to Sales
2.03
EV Over EBITDA
8.8
EV to Operating CashFlow
14.62
EV to FreeCashFlow
34.09
Earnings Yield
0.03
FreeCashFlow Yield
0.04
Market Cap
11,34 Bil.
Enterprise Value
14,42 Bil.
Graham Number
7.35
Graham NetNet
-2.83

Income Statement Metrics

Net Income per Share
0.4
Income Quality
2.8
ROE
0.07
Return On Assets
0.03
Return On Capital Employed
0.11
Net Income per EBT
0.92
EBT Per Ebit
0.39
Ebit per Revenue
0.14
Effective Tax Rate
0.09

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.06
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.69
Operating Profit Margin
0.14
Pretax Profit Margin
0.05
Net Profit Margin
0.05

Dividends

Dividend Yield
0.03
Dividend Yield %
2.89
Payout Ratio
1.11
Dividend Per Share
0.38

Operating Metrics

Operating Cashflow per Share
1.13
Free CashFlow per Share
0.48
Capex to Operating CashFlow
0.57
Capex to Revenue
0.08
Capex to Depreciation
0.83
Return on Invested Capital
0.1
Return on Tangible Assets
0.06
Days Sales Outstanding
71.99
Days Payables Outstanding
172.13
Days of Inventory on Hand
418.72
Receivables Turnover
5.07
Payables Turnover
2.12
Inventory Turnover
0.87
Capex per Share
0.65

Balance Sheet

Cash per Share
0,65
Book Value per Share
5,96
Tangible Book Value per Share
1.13
Shareholders Equity per Share
5.96
Interest Debt per Share
4.22
Debt to Equity
0.68
Debt to Assets
0.33
Net Debt to EBITDA
1.88
Current Ratio
2.51
Tangible Asset Value
0,99 Bil.
Net Current Asset Value
-0,88 Bil.
Invested Capital
8338652163
Working Capital
2,68 Bil.
Intangibles to Total Assets
0.4
Average Receivables
1,38 Bil.
Average Payables
1,02 Bil.
Average Inventory
2491197057
Debt to Market Cap
0.31

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Smith & Nephew plc Dividends
Year Dividends Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Smith & Nephew plc Profile

About Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

CEO
Dr. Deepak S. Nath Ph.D.
Employee
18.000
Address
Building 5
Watford, WD18 8YE

Smith & Nephew plc Executives & BODs

Smith & Nephew plc Executives & BODs
# Name Age
1 Mr. Philip G. Cowdy
Chief Corporate Development & Corporate Affairs Officer
70
2 Ms. Elga Lohler
Chief Human Resources Officer
70
3 Mr. Paul Connolly
President of Global Operations
70
4 Ms. Helen Barraclough
Group General Counsel & Company Secretary
70
5 Mr. Joe Metzger
Senior Vice President of Marketing Services & Communications
70
6 Mr. John Terence Rogers
Chief Financial Officer & Executive Director
70
7 Dr. Vasant Padmanabhan Ph.D.
President of Research & Development and Ear, Nose & Throat
70
8 Dr. Deepak S. Nath Ph.D.
Chief Executive Officer & Director
70
9 Mr. Andrew Swift
Vice President of Investor Relations
70
10 Ms. Alison Parkes
Chief Compliance Officer & Compliance APAC
70

Smith & Nephew plc Competitors